A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 μg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

By Endrikat Jan   Sandri Mirella   Gerlinger Christoph   Rübig Alexander   Schmidt Werner   Fortier Michel  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 220-228

Informa Healthcare

Access to resources Recommend Favorite

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 g ethinyl estradiol combined with 150 g desogestrel or 75 g gestodene

By Zichella L.  

Advances in Contraception, Vol. 15, Iss. 3, 1999-01 ,pp. : 191-200

Springer Publishing Company

Access to resources Recommend Favorite

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 g) and ethinyl estradiol (15 g) on ovarian activity

By Sullivan H.   Furniss H.   Spona J.   Elstein M.  

Fertility and Sterility, Vol. 72, Iss. 1, 1999-07 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite

A randomized, controlled trial of a low-dose contraceptive containing 20 g of ethinyl estradiol and 100 g of levonorgestrel for acne treatment

By Thiboutot D.   Archer D.F.   Lemay A.   Washenik K.   Roberts J.   Harrison D.D.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 461-468

Elsevier

Access to resources Recommend Favorite

Use of an oral contraceptive containing drospirenone in an extended regimen

By Sillem M.   Schneidereit R.   Heithecker R.   Mueck A. O.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 3, 2003-09 ,pp. : 162-169

Informa Healthcare

Access to resources Recommend Favorite